122 related articles for article (PubMed ID: 2453270)
1. The use of the monoclonal antibody Ki-67 in determination of the growth fraction in pediatric brain tumors.
Shibata T; Burger PC
Childs Nerv Syst; 1987; 3(6):364-7. PubMed ID: 2453270
[TBL] [Abstract][Full Text] [Related]
2. The use of the monoclonal antibody Ki-67 in the identification of proliferating cells: application to surgical neuropathology.
Burger PC; Shibata T; Kleihues P
Am J Surg Pathol; 1986 Sep; 10(9):611-7. PubMed ID: 2428262
[TBL] [Abstract][Full Text] [Related]
3. Relationship between Ki-67 positive cells, growth rate and histological type of human intracranial tumors.
Patsouris E; Stocker U; Kallmeyer V; Keiditsch E; Mehraein P; Stavrou D
Anticancer Res; 1988; 8(4):537-44. PubMed ID: 3052245
[TBL] [Abstract][Full Text] [Related]
4. [KI-67 PAP stain for histologic grading of brain tumors by squash preparations].
Shibata T; Ostertag CB; Volk B
No To Shinkei; 1989 Jan; 41(1):55-60. PubMed ID: 2470401
[TBL] [Abstract][Full Text] [Related]
5. Ki-67 immunoperoxidase stain as marker for the histological grading of nervous system tumours.
Shibata T; Burger PC; Kleihues P
Acta Neurochir Suppl (Wien); 1988; 43():103-6. PubMed ID: 2463741
[TBL] [Abstract][Full Text] [Related]
6. The monoclonal antibody Ki-67 as a marker for proliferating cells in stereotactic biopsies of brain tumours.
Ostertag CB; Volk B; Shibata T; Burger P; Kleihues P
Acta Neurochir (Wien); 1987; 89(3-4):117-21. PubMed ID: 3324650
[TBL] [Abstract][Full Text] [Related]
7. Identification of proliferating cells in human gliomas using the monoclonal antibody Ki-67.
Zuber P; Hamou MF; de Tribolet N
Neurosurgery; 1988 Feb; 22(2):364-8. PubMed ID: 2832782
[TBL] [Abstract][Full Text] [Related]
8. Determination of the proliferative potential of human brain tumors using the monoclonal antibody Ki-67.
Deckert M; Reifenberger G; Wechsler W
J Cancer Res Clin Oncol; 1989; 115(2):179-88. PubMed ID: 2715168
[TBL] [Abstract][Full Text] [Related]
9. [Cellular kinetics of cerebral glioma: study of the proliferative activity using monoclonal antibody Ki 67. Apropos of 60 cases].
Parent M; Blond S; Gosset P; Lejeune JP; Lesoin F; Dhellemmes P; Jomin M; Christiaens JL; Dupont A
Arch Anat Cytol Pathol; 1990; 38(3):81-5. PubMed ID: 2363592
[TBL] [Abstract][Full Text] [Related]
10. Growth fraction in human brain tumors defined by the monoclonal antibody Ki-67.
Giangaspero F; Doglioni C; Rivano MT; Pileri S; Gerdes J; Stein H
Acta Neuropathol; 1987; 74(2):179-82. PubMed ID: 3673508
[TBL] [Abstract][Full Text] [Related]
11. The value of cell cycle analysis by propidium-iodine staining of CD56+ cells in pediatric brain tumors.
Vartholomatos G; Alexiou GA; Stefanaki K; Lykoudis EG; Tseka G; Tzoufi M; Sfakianos G; Prodromou N
Clin Neurol Neurosurg; 2015 Jun; 133():70-4. PubMed ID: 25867234
[TBL] [Abstract][Full Text] [Related]
12. Image analysis of proliferating cells in tumors of the human nervous system: an immunohistological study with the monoclonal antibody Ki-67.
Hopf NJ; Bremm J; Bohl J; Perneczky A
Neurosurgery; 1994 Nov; 35(5):917-23; discussion 923. PubMed ID: 7838342
[TBL] [Abstract][Full Text] [Related]
13. Clinical and prognostic significance of Ki-67 and proliferating cell nuclear antigen expression in childhood primitive neuroectodermal brain tumors.
Bodey B; Bodey B; Gröger AM; Siegel SE; Kaiser HE
Anticancer Res; 1997; 17(1A):189-96. PubMed ID: 9066650
[TBL] [Abstract][Full Text] [Related]
14. In situ cell kinetics studies on human neuroectodermal tumors with bromodeoxyuridine labeling.
Hoshino T; Nagashima T; Murovic JA; Wilson CB; Edwards MS; Gutin PH; Davis RL; DeArmond SJ
J Neurosurg; 1986 Mar; 64(3):453-9. PubMed ID: 3950723
[TBL] [Abstract][Full Text] [Related]
15. In situ analysis of cell kinetics in human brain tumors. A comparative immunocytochemical study of S phase cells by a new in vitro bromodeoxyuridine-labeling technique, and of proliferating pool cells by monoclonal antibody Ki-67.
Morimura T; Kitz K; Budka H
Acta Neuropathol; 1989; 77(3):276-82. PubMed ID: 2922990
[TBL] [Abstract][Full Text] [Related]
16. Monoclonal antibody Ki-67 defined growth fraction in benign prostatic hyperplasia and prostatic cancer.
Gallee MP; Visser-de Jong E; ten Kate FJ; Schroeder FH; Van der Kwast TH
J Urol; 1989 Nov; 142(5):1342-6. PubMed ID: 2478729
[TBL] [Abstract][Full Text] [Related]
17. Cell kinetic analysis of brain tumors using the monoclonal antibody Ki-67: in vitro and in situ study.
Shiraishi T
Acta Med Okayama; 1990 Aug; 44(4):187-201. PubMed ID: 2244474
[TBL] [Abstract][Full Text] [Related]
18. Nucleolar organizer region score and Ki-67 labelling index in high-grade gliomas and metastatic brain tumours.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Acta Neurochir (Wien); 1991; 109(1-2):37-41. PubMed ID: 1648862
[TBL] [Abstract][Full Text] [Related]
19. Correlation between nucleolar organizer region staining and Ki-67 immunostaining in human gliomas.
Hara A; Hirayama H; Sakai N; Yamada H; Tanaka T; Mori H
Surg Neurol; 1990 May; 33(5):320-4. PubMed ID: 1691866
[TBL] [Abstract][Full Text] [Related]
20. Quantification of cellular proliferation in acne using the monoclonal antibody Ki-67.
Knaggs HE; Holland DB; Morris C; Wood EJ; Cunliffe WJ
J Invest Dermatol; 1994 Jan; 102(1):89-92. PubMed ID: 8288915
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
